Back to
HRT FINANCIAL LP
HBIO
Showing 2 of 6 quarters
Position history for
HRT FINANCIAL LP's holdings in HARVARD BIOSCIENCE INC
No. HRT Financial exited its HBIO (Harvard Bioscience) position in Q3 2025. Its Q2 2025 13F listed 41,464 shares worth $18,000. HRT Financial first reported HBIO in Q2 2020 and held it in 3 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$18,000
Total Shares Change
-41,464
Quarter-by-Quarter History